Insmed (INSM) Jumps as Morgan Stanley Raises PT by 28% [Yahoo! Finance]
Insmed Incorporated (INSM)
Last insmed incorporated earnings: 4/30 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.insmed.com
Company Research
Source: Yahoo! Finance
Insmed snapped a two-day losing streak on Monday, adding 5.52 percent to close at $153.32 apiece, as investors took path from Morgan Stanley's rating and 28-percent price target upgrade for its stock. In a market note, Morgan Stanley raised its price target for Insmed Inc. (NASDAQ:INSM) to $212 from $166 previously, as well as its rating to “overweight” from “equal weight” amid its optimism for the latter's Brinsupri bronchiectasis launch. The figure marked a 38 percent upside potential from its latest closing price. Is AtaiBeckley Inc (ATAI) Looking to Sell Its Flagship Psychedelic Drug Candidate BPL-003? Photo from Pexels The upgrade reflected its optimism for Insmed Inc.'s (NASDAQ:INSM) treatment for non-cystic fibrosis bronchiectasis (NCFB) called Brinsupri following a US pulmonology survey of 75 pulmonologists, indicating the treatment's durability and depth in the product launch. Based on the study, 85 percent of respondents have already prescribed Brinsupri, with a c
Show less
Read more
Impact Snapshot
Event Time:
INSM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INSM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INSM alerts
High impacting Insmed Incorporated news events
Weekly update
A roundup of the hottest topics
INSM
News
- Insmed (INSM) Is Up 10.0% After Positive ENCORE Data Position ARIKAYCE For Earlier MAC Use [Yahoo! Finance]Yahoo! Finance
- Insmed (INSM) had its price target raised by Barclays PLC from $231.00 to $237.00. They now have an "overweight" rating on the stock.MarketBeat
- Drugmakers delay some European launches with a wary eye on Trump's pricing policies 1 / 2 [Yahoo! Finance Canada]Yahoo! Finance Canada
- Insmed (INSM) was upgraded by Morgan Stanley from "equal weight" to "overweight". They now have a $212.00 price target on the stock.MarketBeat
- Columbia Select Large Cap Growth Fund Q4 2025 Commentary [Seeking Alpha]Seeking Alpha
INSM
Earnings
- 2/19/26 - Miss
INSM
Sec Filings
- 4/3/26 - Form 4
- 4/1/26 - Form 144
- 4/1/26 - Form ARS
- INSM's page on the SEC website